Heidemarie Dobias

Publikationen

Publikationen pro Jahr 2010 2021 2024

• 13 Originalarbeit
• 5 Abstrakt (Zeitschrift)
• 3 Poster
• 2 Abstrakt
• 2 Mehr
  • 1 Buch
  • 1 Kurzbericht / Notes

Publikationen pro Jahr

Publikationen pro Jahr

Suchergebnisse

• 2024

  The efficacy of ferroptosis-inducing compounds IKE and RSL3 correlates with the expression of ferroptotic pathway regulators CD71 and SLC7A11 in biliary tract cancer cells

  Bekric, D. (Erstautor/-in), Kiesslich, T. (Co-Autor/-in), Ocker, M., Winklmayr, M. (Co-Autor/-in), Ritter, M. (Co-Autor/-in), Dobias, H. (Co-Autor/-in), Beyreis, M. (Co-Autor/-in), Neureiter, D. (Co-Autor/-in) & Mayr, C. (Letztautor/-in), 11 Apr. 2024, in: PLOS ONE. 19, 4, S. e0302050 22 S., e0302050.

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

  Open Access

  • Cancer Cell 100%
  • Ferroptosis 100%
  • Hepatobiliary System 100%
  • Biliary Tract Cancer 100%
  • Solute Carrier Family 7 Member 11 100%
• 2023

  Evaluation of Tazemetostat as a Therapeutically Relevant Substance in Biliary Tract Cancer

  Bekric, D. (Erstautor/-in), Neureiter, D. (Co-Autor/-in), Ablinger, C., Dobias, H. (Co-Autor/-in), Beyreis, M. (Co-Autor/-in), Ritter, M. (Co-Autor/-in), Jakab, M. (Co-Autor/-in), Bischof, J. (Co-Autor/-in), Koller, U. (Co-Autor/-in), Kiesslich, T. (Co-Autor/-in) & Mayr, C. R. (Letztautor/-in), 2 März 2023, in: Cancers. 15, 5

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
  7 Quellenangaben (Web of Science)

• Ouabain at nanomolar concentrations is cytotoxic for biliary tract cancer cells

  Mayr, C. R. (Erstautor/-in), Kiesslich, T. (Co-Autor/-in), Bekric, D. (Co-Autor/-in), Beyreis, M. (Co-Autor/-in), Kittl, M. (Co-Autor/-in), Ablinger, C., Neureiter, E., Pichler, M., Prinz, F., Ritter, M. (Co-Autor/-in), Neureiter, D. (Co-Autor/-in), Jakab, M. (Co-Autor/-in) & Dobias, H. (Letztautor/-in), 30 Juni 2023, in: PLOS ONE. 18, 6, S. e0287769

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
  1 Quellenangabe (Web of Science)
• 2022

  Sustained improvements in EQ-5D utility scores and self-rated health status in patients with ankylosing spondylitis after spa treatment including low-dose radon - an analysis of prospective radon indication registry data

  van der Zee-neuen, A. (Erstautor/-in), Strobl, V. (Co-Autor/-in), Dobias, H. (Co-Autor/-in), Fuchs, J. (Co-Autor/-in), Untner, J., Foisner, W., Knapp, M., Edtinger, S. (Co-Autor/-in), Offenbaecher, M., Ritter, M. (Letztautor/-in), Hoelzl, B. & Gaisberger, M. (Letztautor/-in), 2022, in: BMC MUSCULOSKELETAL DISORDERS. 23, 1, S. 743

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
  2 Quellenangaben (Web of Science)
• 2021

  Endogenous anandamide and self-reported pain are significantly reduced after a 2-week multimodal treatment with and without radon therapy in patients with knee osteoarthritis: a pilot study.

  Gaisberger, M. (Erstautor/-in), Fuchs, J., Riedl, M. (Co-Autor/-in), Edtinger, S., Reischl, R., Grasmann, G., Hölzl, B., Landauer, F. (Co-Autor/-in), Dobias, H. (Co-Autor/-in), Eckstein, F. (Co-Autor/-in), Offenbächer, M., Ritter, M. (Co-Autor/-in) & Winklmayr, M. (Letztautor/-in), 1 März 2021, in: INTERNATIONAL JOURNAL OF BIOMETEOROLOGY. 65, 7, S. 1151-1160

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
  5 Quellenangaben (Web of Science)

• HDAC Class I Inhibitor Romidepsin as a novel and promising Epigenetic Drug for Biliary Tract Cancer.

  Mayr, C. R., Kiesslich, T., Erber, S., Bekric, D., Dobias, H., Ritter, M., Jäger, T., Neumayer, Klieser, E. & Neureiter, D., 2021.

  Publikation: Konferenzbeitrag › Abstrakt

• HDAC Class I Inhibitor Romidepsin as a novel and promising Epigenetic Drug for Biliary Tract Cancer.

  Mayr, C. R., Kiesslich, T., Erber, S., Bekric, D., Dobias, H., Ritter, M., Jäger, T., Neumayer, Klieser, E. & Neureiter, D., 2021.

  Publikation: Konferenzbeitrag › Poster

• HDAC Screening identifies the HDAC Class I Inhibitor Romidepsin as a promising Epigenetic Drug for Biliary Tract Cancer

  Mayr, C., Kiesslich, T., Erber, S., Bekric, D., Dobias, H., Beyreis, M., Ritter, M., Jager, T., Neumayer, B., Winkelmann, P., Klieser, E. & Neureiter, D., 2021, in: FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
  8 Quellenangaben (Web of Science)

• HDAC Screening identifies the HDAC Class I Inhibitor Romidepsin as a promising Epigenetic Drug for Biliary Tract Cancer

  Mayr, C., Kiesslich, T., Erber, S., Bekric, D., Dobias, H., Beyreis, M., Ritter, M., Jager, T., Neumayer, B., Winkelmann, P., Klieser, E. & Neureiter, D., Mai 2021. 2 S.

  Publikation: Konferenzbeitrag › Poster › Begutachtung
  8 Quellenangaben (Web of Science)

• HDAC Screening Identifies the HDAC Class I Inhibitor Romidepsin as a Promising Epigenetic Drug for Biliary Tract Cancer

  Mayr, C. R. (Erstautor/-in), Kiesslich, T. (Co-Autor/-in), Erber, S., Bekric, D., Dobias, H. (Co-Autor/-in), Beyreis, M. (Co-Autor/-in), Ritter, M. (Co-Autor/-in), Jäger, T. (Co-Autor/-in), Neumayer, B. (Co-Autor/-in), Winkelmann, P., Klieser, E. (Co-Autor/-in) & Neureiter, D. (Letztautor/-in), 31 Juli 2021, in: Cancers. 13, 15

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
  11 Quellenangaben (Web of Science)

• HDAC-targeting epigenetic drug screening for biliary tract cancer.

  Mayr, C. R. (Erstautor/-in), Kiesslich, T. (Co-Autor/-in), Erber, S., Bekric, D., Dobias, H. (Co-Autor/-in), Ritter, M. (Co-Autor/-in), Jäger, T. (Co-Autor/-in), Neumayer, B. (Co-Autor/-in), Winkelmann, P., Klieser, E. (Co-Autor/-in) & Neureiter, D. (Letztautor/-in), 2021, in: ANNALS OF HEPATO-BILIARY-PANCREATIC SURGERY. 25, Suppl 1, S. S397

  Publikation: Beitrag in Fachzeitschrift › Kurzbericht / Notes › Begutachtung

• HDAC-targeting Epigenetic Drug Screening for Biliary Tract Cancer.

  Mayr, C. R. (Erstautor/-in), Kiesslich, T. (Co-Autor/-in), Erber, S. (Co-Autor/-in), Bekric, D. (Co-Autor/-in), Dobias, H. (Co-Autor/-in), Ritter, M. (Co-Autor/-in), Jäger, T. (Co-Autor/-in), Neumayer, B. (Co-Autor/-in), Winkelmann, P. (Co-Autor/-in), Klieser, E. (Co-Autor/-in) & Neureiter, D. (Letztautor/-in), 2021.

  Publikation: Konferenzbeitrag › Poster

• HDAC-targeting Epigenetic Drug Screening for Biliary Tract Cancer.

  Mayr, C. R. (Erstautor/-in), Kiesslich, T. (Co-Autor/-in), Erber, S. (Co-Autor/-in), Bekric, D. (Co-Autor/-in), Dobias, H. (Co-Autor/-in), Ritter, M. (Co-Autor/-in), Jäger, T. (Co-Autor/-in), Neumayer, B. (Co-Autor/-in), Winkelmann, P. (Co-Autor/-in), Klieser, E. (Co-Autor/-in) & Neureiter, D. (Letztautor/-in), 2021.

  Publikation: Konferenzbeitrag › Abstrakt
• 2020

  Acute Exposure to Environmental Tobacco Smoke: A Controlled Study in Adults with Asthma.

  Gaisberger, M. (Erstautor/-in), Wass, R. E., Dobias, H. (Co-Autor/-in), Grabcanovic-Musija, F. (Co-Autor/-in), Weiss, G. (Co-Autor/-in), Lamprecht, B., Kaiser, B., Studnicka, M. (Letztautor/-in) & Hartl, A. J. (Letztautor/-in), 2020, in: RESPIRATION . S. 1-8

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
  2 Quellenangaben (Web of Science)
• 2019

  Continuous, label-free, 96-well-based determination of cell migration using confluence measurement.

  Mayr, C. R. (Erstautor/-in), Beyreis, M. (Co-Autor/-in), Dobias, H. (Co-Autor/-in), Gaisberger, M. (Co-Autor/-in), Fuchs, J., Pichler, M., Ritter, M. (Co-Autor/-in), Jakab, M. (Co-Autor/-in), Helm, K. (Co-Autor/-in), Neureiter, D. (Co-Autor/-in) & Kiesslich, T. (Letztautor/-in), 2019, in: CELL ADHESION & MIGRATION. 13, 1, S. 76-82

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
  1 Quellenangabe (Web of Science)
• 2018

  Glycine Induces Migration of Microglial BV-2 Cells via SNAT-Mediated Cell Swelling.

  Kittl, M. (Erstautor/-in), Dobias, H. (Co-Autor/-in), Beyreis, M. (Co-Autor/-in), Kiesslich, T. (Co-Autor/-in), Mayr, C. R. (Co-Autor/-in), Gaisberger, M. (Co-Autor/-in), Ritter, M. (Co-Autor/-in), Kerschbaum, H. H. & Jakab, M. (Letztautor/-in), 2018, in: Cellular physiology and biochemistry. 50, 4, S. 1460-1473

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
  11 Quellenangaben (Web of Science)

• Miniaturization of the Clonogenic Assay Using Confluence Measurement.

  Mayr, C. R. (Erstautor/-in), Beyreis, M. (Co-Autor/-in), Dobias, H. (Co-Autor/-in), Gaisberger, M. (Co-Autor/-in), Pichler, M., Ritter, M. (Co-Autor/-in), Jakab, M. (Co-Autor/-in), Neureiter, D. (Co-Autor/-in) & Kiesslich, T. (Letztautor/-in), 2018, in: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 19, 3

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
  8 Quellenangaben (Web of Science)
• 2017

  Glycine uptake via sodium/neutral amino acid transporters activates a swelling-dependent anion conductance in microglial cells

  Kittl, M., Beyreis, M., Dobias, H., Gaisberger, M., Ritter, M., Kerschbaum, H. & Jakab, M., 2017, in: ACTA PHYSIOLOGICA (OXFORD, ENGLAND). 219, S. 86-86

  Publikation: Beitrag in Fachzeitschrift › Abstrakt (Zeitschrift) › Begutachtung

• Glycine Uptake via Sodiuml Neutral Amino Acid Transporters Activates a Swelling-Dependent Anion Conductance in Microglial Cells

  Jakab, M., Kittl, M., Beyreis, M., Dobias, H., Gaisberger, M., Ritter, M. & Kerschbaum, H., 2017, in: ACTA PHYSIOLOGICA (OXFORD, ENGLAND). 221, S. 202-202

  Publikation: Beitrag in Fachzeitschrift › Abstrakt (Zeitschrift) › Begutachtung

• The effect of Napabucasin on cancer stem cells in biliary tract cancer

  Beyreis, M., Helm, K., Dobias, H., Jakab, M., Ritter, M., Neureiter, D., Kiesslich, T. & Mayr, C. R., 2017, in: ACTA PHYSIOLOGICA (OXFORD, ENGLAND). 221, S. 252-252

  Publikation: Beitrag in Fachzeitschrift › Abstrakt (Zeitschrift) › Begutachtung
• 2014

  The projected increase of rheumatoid diseases due to an aging population in Austria from 2012 to 2050

  Ritter, M., Moder, A., Hitzl, W., Gaisberger, M. & Dobias, H., 2014, in: ACTA PHYSIOLOGICA (OXFORD, ENGLAND). 211, S. 182-182

  Publikation: Beitrag in Fachzeitschrift › Abstrakt (Zeitschrift) › Begutachtung
• 2013

  Effects of Low-Dose Radon Therapy Applied Under Hyperthermic Conditions (RnHT) on Inflammatory and Non-Inflammatory Degenerative Disease Conditions

  Moder, M., Dobias, H. & Ritter, M., 2013, InTech.

  Publikation: Buch/Bericht › Buch
• 2012

  Effects of ionized waterfall aerosol on pediatric allergic asthma.

  Gaisberger, M. (Erstautor/-in), Šanović, R., Dobias, H. (Co-Autor/-in), Kolarž, P., Moder, A., Thalhamer, J., Selimović, A., Huttegger, I. (Co-Autor/-in), Ritter, M. (Co-Autor/-in) & Hartl, A. J. (Letztautor/-in), 2012, in: JOURNAL OF ASTHMA. 49, 8, S. 830-838

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
  19 Quellenangaben (Web of Science)

• RADON THERAPY AMELIORATES DISEASE PROGRESSION AND PROLONGS SURVIVAL IN TNF alpha TG MICE

  Pauthner, M., Janko, C., Baum, W., Schorn, C., Dobias, H., Moder, A., Schett, G. & Herrmann, M., 2012, in: ANNALS OF THE RHEUMATIC DISEASES. 71

  Publikation: Beitrag in Fachzeitschrift › Abstrakt (Zeitschrift) › Begutachtung
• 2010

  Designing hypoallergenic derivatives for allergy treatment by means of in silico mutation and screening.

  Thalhamer, T., Dobias, H. (Erstautor/-in), Stepanoska, T., Pröll, M., Stutz, H., Dissertori, O., Lackner, P., Ferreira, F., Wallner, M., Thalhamer, J. & Hartl, A. J. (Letztautor/-in), 2010, in: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY . 125, 4, S. 926-934.e10

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
  34 Quellenangaben (Web of Science)